Last Updated 21 April 2021.
3 Vaccines Approved for Use in Republic of Korea
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 83 countries
18 trials in 12 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 40 countries
8 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 91 countries
24 trials in 15 countries
7 Vaccines in Clinical Trials in Republic of Korea
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
GeneOne Life Science Inc
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country